Lexaria Bioscience Corp (LEXX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
6,909,300
EV to revenue ratio (TTM)
16.93
EV to ebitda
-7.22
Financial Performance
Revenue (TTM)
194,000
Gross profit (TTM)
194,000
EBITDA
-7,417,538
Profitability
Operating margin (TTM)
-3,863.00%
Profit margin
0.00%
Return on assets (TTM)
-81.30%
Return on equity (TTM)
-162.80%
Per Share Metrics
Revenue per share (TTM)
0.13
EPS
-5.03
Diluted EPS (TTM)
-5.03
Book value
2.87
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
35.61
Price to book ratio (TTM)
1.438
Growth
Quarterly earnings growth (YoY)
-88.50%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
1
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.494